N4 Pharma (LON:N4P) Shares Down 15% – Should You Sell?

N4 Pharma Plc (LON:N4P)’s share price fell 15% during mid-day trading on Monday . The company traded as low as GBX 0.50 ($0.01) and last traded at GBX 0.51 ($0.01). 406,630 shares changed hands during trading, an increase of 42% from the average session volume of 287,200 shares. The stock had previously closed at GBX 0.60 ($0.01).

N4 Pharma Price Performance

The stock’s 50 day simple moving average is GBX 0.63 and its 200-day simple moving average is GBX 0.57. The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 22.73. The firm has a market cap of £2.01 million, a price-to-earnings ratio of -55.00 and a beta of -0.37.

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.